
News|Videos|June 6, 2018 (Updated: May 8, 2025)
Exploring the Changing Landscape of ICI Tx in NSCLC
Author(s)Leena Gandhi, MD
In this video, Dr. Leena Gandhi discusses KEYNOTE-042, a study of pembrolizumab vs chemotherapy in NSCLC (abstract LBA4), and other key ICI trials reported at ASCO 2018.
Advertisement
In this video, Dr. Leena Gandhi discusses KEYNOTE-042, a study of pembrolizumab vs chemotherapy in NSCLC (abstract LBA4), and other key ICI trials reported at ASCO 2018.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Related Content
Advertisement


Optimizing the Use of Hypofractionated Radiotherapy in Lung Cancer Care
Published: | Updated:



Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Removes Black Box Warning for Breast Cancer and Other Indications on HRT Products
2
How Tolerable is Pembrolizumab/Paclitaxel/Bevacizumab in PROC?
3
Neoadjuvant Therapy Improves Survival in Upfront Resectable PDAC Subtype
4
Hypofractionation is ‘Excellent Tool’ in Radiotherapy for Lung Cancer
5






































